GTR 86724621
Tenders Are Invited For Ravulizumab 300 Mg/3 Ml Concentrate For Solution For Injection
ICB — International Competitive Bid
Closed
Asia
Tender Information
GTR Reference
86724621
Tendering Authority
Subscribe to view
Tender No
MED/20/2024/A
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Ravulizumab 300 Mg/3 Ml Concentrate For Solution For Injection
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Asia
Political Region
Arab World1,Middle East,Middle East and North Africa, MENA
Last Date of Bid Submission
16-10-2024
Closed
Work Detail
Tenders are invited for Ravulizumab 300 Mg/3 Ml Concentrate for Solution for Injection (Iv Infusion) Vial 1213. Payment of a nonrefundable fee with lump sum as follows: a- (1.000.000)one million Iraqi Dinar of the tender that less than (1.000.000) Dollars . b- (2.000.000)two million Iraqi Dinar for the tender that more than (1.000.000) Dinar A Bid Security at ratio 1% Tender Link : https://kimadia.gov.iq/en/category/medicines/
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
68cf3173-9d5b-44b3-8a77-3ee02083df0b.zip
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.